187 related articles for article (PubMed ID: 25311421)
1. Stability profiling of anti-malarial drug piperaquine phosphate and impurities by HPLC-UV, TOF-MS, ESI-MS and NMR.
Yan F; Liu J; Zeng X; Zhang Y; Hang T
Malar J; 2014 Oct; 13():401. PubMed ID: 25311421
[TBL] [Abstract][Full Text] [Related]
2. Characterization and quantitative determination of impurities in piperaquine phosphate by HPLC and LC/MS/MS.
Dongre VG; Karmuse PP; Ghugare PD; Gupta M; Nerurkar B; Shaha C; Kumar A
J Pharm Biomed Anal; 2007 Jan; 43(1):186-95. PubMed ID: 16916594
[TBL] [Abstract][Full Text] [Related]
3. Stability-indicating HPLC-DAD/UV-ESI/MS impurity profiling of the anti-malarial drug lumefantrine.
Verbeken M; Suleman S; Baert B; Vangheluwe E; Van Dorpe S; Burvenich C; Duchateau L; Jansen FH; De Spiegeleer B
Malar J; 2011 Feb; 10():51. PubMed ID: 21356068
[TBL] [Abstract][Full Text] [Related]
4. Identification of an isomer impurity in piperaquine drug substance.
Lindegårdh N; Giorgi F; Galletti B; Di Mattia M; Quaglia M; Carnevale D; White NJ; Mazzanti A; Day NP
J Chromatogr A; 2006 Dec; 1135(2):166-9. PubMed ID: 17046006
[TBL] [Abstract][Full Text] [Related]
5. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
6. Identification, Characterization, and Quantification of Impurities of Safinamide Mesilate: Process-Related Impurities and Degradation Products.
Zou L; Sun L; Zhang H; Hui W; Zou Q; Zhu Z
J AOAC Int; 2017 Jul; 100(4):1029-1037. PubMed ID: 28150570
[TBL] [Abstract][Full Text] [Related]
7. Potential impurities of anxiolytic drug, clobazam: Identification, synthesis and characterization using HPLC, LC-ESI/MS
Kumar N; Devineni SR; Dubey SK; Kumar P
J Pharm Biomed Anal; 2017 Apr; 137():268-278. PubMed ID: 28183048
[TBL] [Abstract][Full Text] [Related]
8. Isolation, structure characterization and quantification of related impurities in asperosaponin VI.
Ji D; Liu YF; Wang QH; Zhang CF; Yang ZL
Chin J Nat Med; 2013 Jul; 11(4):419-26. PubMed ID: 23845554
[TBL] [Abstract][Full Text] [Related]
9. Isolation, identification and characterization of potential impurities of anidulafungin.
Zhao L; Wang Q; Bie Y; Lu X
J Pharm Biomed Anal; 2017 Jul; 141():192-199. PubMed ID: 28448888
[TBL] [Abstract][Full Text] [Related]
10. Four process-related potential new impurities in ticagrelor: Identification, isolation, characterization using HPLC, LC/ESI-MS(n), NMR and their synthesis.
Kumar N; Devineni SR; Gajjala PR; Gupta DK; Bhat S; Kumar R; Dubey SK; Kumar P
J Pharm Biomed Anal; 2016 Feb; 120():248-60. PubMed ID: 26760243
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of process related impurities in chloroquine and hydroxychloroquine by LC/IT/MS, LC/TOF/MS and NMR.
Dongre VG; Ghugare PD; Karmuse P; Singh D; Jadhav A; Kumar A
J Pharm Biomed Anal; 2009 May; 49(4):873-9. PubMed ID: 19201565
[TBL] [Abstract][Full Text] [Related]
12. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry.
Dongre VG; Karmuse PP; Ghugare PD; Kanojiya SK; Rawal S
Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2227-33. PubMed ID: 18543378
[TBL] [Abstract][Full Text] [Related]
13. Identification, characterization and HPLC quantification of process-related impurities in Trelagliptin succinate bulk drug: Six identified as new compounds.
Zhang H; Sun L; Zou L; Hui W; Liu L; Zou Q; Ouyang P
J Pharm Biomed Anal; 2016 Sep; 128():18-27. PubMed ID: 27209451
[TBL] [Abstract][Full Text] [Related]
14. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
[TBL] [Abstract][Full Text] [Related]
15. Impurity Profile of Bronchodilators used in Asthma: A Critical Review.
Prajapati KJ; Kothari CS
Curr Drug Discov Technol; 2018; 15(4):272-304. PubMed ID: 28875855
[TBL] [Abstract][Full Text] [Related]
16. Isolation, identification, and characterization of potential impurities of doramectin and evaluation of their insecticidal activity.
Zhang Q; Cheng Y; Yang J; Zheng C; Lu X
J Pharm Biomed Anal; 2020 Nov; 191():113600. PubMed ID: 32977199
[TBL] [Abstract][Full Text] [Related]
17. Identification, synthesis and structural characterization of process related and degradation impurities of acrivastine and validation of HPLC method.
Kumar A; Devineni SR; Dubey SK; Kumar P; Srivastava V; Ambulgekar G; Jain M; Gupta DK; Singh G; Kumar R; Hiriyanna SG; Kumar P
J Pharm Biomed Anal; 2017 Jan; 133():15-26. PubMed ID: 27969063
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of unknown degradation impurities in beclomethasone dipropionate cream formulation using HPLC, ESI-MS and NMR.
Sambandan E; Kathavarayan T; Sellappan S; Shiea J; Ponnusamy VK
J Pharm Biomed Anal; 2019 Apr; 167():123-131. PubMed ID: 30771645
[TBL] [Abstract][Full Text] [Related]
19. LC-HRMS and NMR studies for the characterization of degradation impurities of ubrogepant along with the in silico approaches for the prediction of degradation and toxicity.
Chaganti S; Chauhan U; Bhatt N; Kommalapati H; Golla VM; Pilli P; Samanthula G
J Pharm Biomed Anal; 2024 Jun; 243():116117. PubMed ID: 38522383
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of the process-related impurities in fasudil hydrochloride by hyphenated techniques using a quality by design approach.
Song M; Chen YQ; Lu PB; Hang TJ
J Sep Sci; 2014 Apr; 37(7):758-63. PubMed ID: 24470347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
